VERO BEACH, Fla., Feb. 19, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced that it will no longer sponsor the 13 C-sucrose breath test ...
Congenital Sucrase-Isomaltase Deficiency (CSID) is largely a clinical diagnosis that requires a thorough review of the patient's medical history. While there are several tests available to aid in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback